Epithelial cell adhesion molecule EpCAM is expressed on a subset of normal epithelia and overexpressed on malignant cells from a variety of different tumor entities. This overexpression is even more pronounced on so-called tumor-initiating cells (TICs) of many carcinomas. Taking this rather ubiquitous expression of EpCAM in carcinomas and TICs into account, the question arises how EpCAM can serve as a reliable marker for tumor-initiating cells and what might be the advantage for TICs to express this molecule. Furthermore, several approaches for therapeutic strategies targeting exclusively EpCAM on cancer cells were undertaken over the past decades and have recently been transferred to pre-clinical attempts to eradicate TICs. In the present review, we will depict potential functions of EpCAM in tumor cells with a special focus on TICs and therapeutic implications.

Sannia Imrich

Matthias Hachmeister

Olivier Gires

Cell Adhesion & Migration

Cell Adhesion and Migration

EpCAM and its potential role in tumor-initiating cells

Potential functions of EpCAM in tumor cells with a special focus on TICs and therapeutic implications are depicted and several approaches for therapeutic strategies targeting exclusively EpCam on cancer cells are undertaken.

Category	Quartile
生物学	3
生物学, 细胞生物学	4

EpCAM and its potential role in tumor-initiating cells

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
CELL BIOLOGY	3